Methods of inhibiting pneumocystis carinii pneumonia and compoun

Details Methods of inhibiting pneumocystis carinii pneumonia and compoun Methods of inhibiting pneumocystis carinii pneumonia and compoun

1995-06-07

1997-09-16

Travers, Russell

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 3140

Patent

active

056681666

ABSTRACT:
The present invention provides methods for treating Pneumocystis carinii pneumonia. The method comprises administering to the subject a compound of Formula I: ##STR1## wherein: X is located in the para or meta positions and is loweralkyl, loweralkoxy, alkoxyalkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl, cycloalkyl, aryl, alkylaryl, halogen, or ##STR2## wherein: each R.sub.2 is independently selected from the group consisting of H, loweralkyl, alkoxyalkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl, cycloalkyl, aryl, or alkylaryl or two R.sub.2 groups together represent C.sub.2 -C.sub.10 alkylene, or two R.sub.2 groups together represent ##STR3## wherein m is from 1-3 and R.sub.4 is H, ##STR4## or --CONHR.sub.5 NR.sub.6 R.sub.7, wherein R.sub.5 is loweralkyl, R.sub.6 and R.sub.7 are each independently selected from the group consisting of H and lower alkyl; each R.sub.8 is independently selected from the group consisting of H, loweralkyl, alkoxyalkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl, cycloalkyl, aryl, or alkylaryl, or two R.sub.8 groups together represent C.sub.2 -C.sub.10 alkylene; R.sub.9 is H, hydroxy, loweralkyl, alkoxyalkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl, cycloalkyl, aryl, or alkylaryl;

REFERENCES:
patent: 4933347 (1990-06-01), Tidwell et al.
patent: 4963589 (1990-10-01), Tidwell et al.
Ram et al 118 CA: 254855t 1993.
Randelia et al 97 CA: 35933m 1982.
Shukla et al 121 CA: 255584c 1994.
Edman et al 109 CA: 125671v 1988.
S. Jones et al.; Novel Pentamidine Analogs in the Treatment of Experimental Pneumocystis Carinii Pneumonia. Antimicrob. Agents Chemother. 34: 1026-1030 (1990).
B. Berger et al.; Metabolic N-Hydroxylation of Pentamidine In Vitro. Antimicrob. Agents Chemother. 34: 1678-1684 (1990).
R. Tidwell et al.; Analogues of 1,5-Bis(4-amidinophenoxy)pentane (Pentamidine) in the Treatment of Experimental Pneumocystis carinii Pneumonia. J. Med. Chem 33:1252-1257 (1990).
I. Donkor et al.; Pentamidine Congeners. 2. 2-Butene-Bridged Aromatic Diamidines and Diimidazolines as Potential Anti-Pneumocystis carinii Pneumonia Agents. J. Med. Chem. 37:4554-4557 (1994).
M.Cory et al.; Structure and DNA Binding Activity of Analogues of 1,5-Bis(4-amidinophenoxy)pentane (Pentamidine). J. Med. Chem. 35:431-438 (1992).
Ram et al.; Chemotheraputic agents. XXV. Synthesis and leichmanicidal activity of carbazolylpyrimidines, Chemical Abstracts, 118, No. 25, p. 878, col. 2, abst. #254855t, Eur J Med Chem 27(8):851-5 (21 Jun. 1993).
Bassin et al.; Chlorosulfonation of some polynuclear heterocyclic compounds, Chemical Abstracts, 118, No. 25, p. 854, col. 1-2, abst. #254658f, Phosphorus, Sulfur, Silicon Relat. Elem., 72(1-4), pp. 157-170 (21 Jun. 1993).
PCT Search Report for PCT/US96/08464. 1996.

Affiliated with

Also associated with

Rating

Methods of inhibiting pneumocystis carinii pneumonia and compoun does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of inhibiting pneumocystis carinii pneumonia and compoun, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inhibiting pneumocystis carinii pneumonia and compoun will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-218740